INFUSYSTEM HOLDINGS INC (INFU) Stock Fundamental Analysis

USA • NYSE Arca • NYSEARCA:INFU • US45685K1025

7.57 USD
-0.19 (-2.45%)
Last: Feb 5, 2026, 08:04 PM
Fundamental Rating

6

Overall INFU gets a fundamental rating of 6 out of 10. We evaluated INFU against 102 industry peers in the Health Care Providers & Services industry. INFU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. INFU has a correct valuation and a medium growth rate. These ratings could make INFU a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • INFU had positive earnings in the past year.
  • In the past year INFU had a positive cash flow from operations.
  • In the past 5 years INFU has always been profitable.
  • In the past 5 years INFU always reported a positive cash flow from operatings.
INFU Yearly Net Income VS EBIT VS OCF VS FCFINFU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.03%, INFU is in the better half of the industry, outperforming 77.45% of the companies in the same industry.
  • With a decent Return On Equity value of 9.30%, INFU is doing good in the industry, outperforming 69.61% of the companies in the same industry.
  • INFU has a Return On Invested Capital of 9.55%. This is in the better half of the industry: INFU outperforms 78.43% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for INFU is significantly below the industry average of 9.16%.
  • The 3 year average ROIC (3.86%) for INFU is below the current ROIC(9.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.03%
ROE 9.3%
ROIC 9.55%
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
INFU Yearly ROA, ROE, ROICINFU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.63%, INFU is in the better half of the industry, outperforming 72.55% of the companies in the same industry.
  • In the last couple of years the Profit Margin of INFU has remained more or less at the same level.
  • INFU's Operating Margin of 7.35% is fine compared to the rest of the industry. INFU outperforms 73.53% of its industry peers.
  • In the last couple of years the Operating Margin of INFU has grown nicely.
  • With a decent Gross Margin value of 54.55%, INFU is doing good in the industry, outperforming 77.45% of the companies in the same industry.
  • In the last couple of years the Gross Margin of INFU has declined.
Industry RankSector Rank
OM 7.35%
PM (TTM) 3.63%
GM 54.55%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
INFU Yearly Profit, Operating, Gross MarginsINFU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • INFU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • INFU has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for INFU has been increased compared to 5 years ago.
  • The debt/assets ratio for INFU has been reduced compared to a year ago.
INFU Yearly Shares OutstandingINFU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
INFU Yearly Total Debt VS Total AssetsINFU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 3.09 indicates that INFU is not in any danger for bankruptcy at the moment.
  • INFU has a Altman-Z score of 3.09. This is in the better half of the industry: INFU outperforms 65.69% of its industry peers.
  • INFU has a debt to FCF ratio of 1.97. This is a very positive value and a sign of high solvency as it would only need 1.97 years to pay back of all of its debts.
  • INFU's Debt to FCF ratio of 1.97 is amongst the best of the industry. INFU outperforms 81.37% of its industry peers.
  • INFU has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of INFU (0.48) is better than 61.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 1.97
Altman-Z 3.09
ROIC/WACC1.07
WACC8.9%
INFU Yearly LT Debt VS Equity VS FCFINFU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 2.19 indicates that INFU has no problem at all paying its short term obligations.
  • The Current ratio of INFU (2.19) is better than 80.39% of its industry peers.
  • A Quick Ratio of 1.84 indicates that INFU should not have too much problems paying its short term obligations.
  • INFU has a better Quick ratio (1.84) than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 1.84
INFU Yearly Current Assets VS Current LiabilitesINFU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 333.33% over the past year.
  • The Earnings Per Share has been growing by 10.59% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 7.22% in the past year.
  • INFU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.70% yearly.
EPS 1Y (TTM)333.33%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%37.5%
Revenue 1Y (TTM)7.22%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%3.31%

3.2 Future

  • Based on estimates for the next years, INFU will show a very strong growth in Earnings Per Share. The EPS will grow by 68.50% on average per year.
  • INFU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.05% yearly.
EPS Next Y195.8%
EPS Next 2Y104.8%
EPS Next 3Y68.5%
EPS Next 5YN/A
Revenue Next Year5.85%
Revenue Next 2Y4.37%
Revenue Next 3Y5.87%
Revenue Next 5Y7.05%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INFU Yearly Revenue VS EstimatesINFU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
INFU Yearly EPS VS EstimatesINFU Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 29.12 indicates a quite expensive valuation of INFU.
  • INFU's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.67. INFU is around the same levels.
  • Based on the Price/Forward Earnings ratio of 18.05, the valuation of INFU can be described as rather expensive.
  • INFU's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. INFU is cheaper than 65.69% of the companies in the same industry.
  • INFU's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
Industry RankSector Rank
PE 29.12
Fwd PE 18.05
INFU Price Earnings VS Forward Price EarningsINFU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • INFU's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. INFU is cheaper than 80.39% of the companies in the same industry.
  • INFU's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INFU is cheaper than 80.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.51
EV/EBITDA 7.64
INFU Per share dataINFU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • INFU has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as INFU's earnings are expected to grow with 68.50% in the coming years.
PEG (NY)0.15
PEG (5Y)2.75
EPS Next 2Y104.8%
EPS Next 3Y68.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • INFU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INFUSYSTEM HOLDINGS INC

NYSEARCA:INFU (2/5/2026, 8:04:00 PM)

7.57

-0.19 (-2.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)03-02
Inst Owners75.72%
Inst Owner Change-0.18%
Ins Owners4.8%
Ins Owner Change0.34%
Market Cap153.97M
Revenue(TTM)134.86M
Net Income(TTM)5.07M
Analysts83.64
Price Target14.48 (91.28%)
Short Float %0.91%
Short Ratio1.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)151.14%
Min EPS beat(2)75.49%
Max EPS beat(2)226.8%
EPS beat(4)3
Avg EPS beat(4)69.56%
Min EPS beat(4)-48.06%
Max EPS beat(4)226.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.63%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)4
Avg Revenue beat(8)-0.36%
Revenue beat(12)6
Avg Revenue beat(12)-0.46%
Revenue beat(16)7
Avg Revenue beat(16)-1.59%
PT rev (1m)0%
PT rev (3m)3.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)13.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.18%
Valuation
Industry RankSector Rank
PE 29.12
Fwd PE 18.05
P/S 1.1
P/FCF 11.51
P/OCF 5.8
P/B 2.82
P/tB 3.53
EV/EBITDA 7.64
EPS(TTM)0.26
EY3.43%
EPS(NY)0.42
Fwd EY5.54%
FCF(TTM)0.66
FCFY8.69%
OCF(TTM)1.31
OCFY17.25%
SpS6.88
BVpS2.68
TBVpS2.15
PEG (NY)0.15
PEG (5Y)2.75
Graham Number3.96
Profitability
Industry RankSector Rank
ROA 5.03%
ROE 9.3%
ROCE 12.09%
ROIC 9.55%
ROICexc 9.63%
ROICexgc 11.06%
OM 7.35%
PM (TTM) 3.63%
GM 54.55%
FCFM 9.57%
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexgc growth 3Y31.39%
ROICexgc growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 1.97
Debt/EBITDA 1.12
Cap/Depr 99.64%
Cap/Sales 9.42%
Interest Coverage 250
Cash Conversion 113.02%
Profit Quality 263.84%
Current Ratio 2.19
Quick Ratio 1.84
Altman-Z 3.09
F-Score9
WACC8.9%
ROIC/WACC1.07
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)333.33%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%37.5%
EPS Next Y195.8%
EPS Next 2Y104.8%
EPS Next 3Y68.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.22%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%3.31%
Revenue Next Year5.85%
Revenue Next 2Y4.37%
Revenue Next 3Y5.87%
Revenue Next 5Y7.05%
EBIT growth 1Y159.69%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year323.27%
EBIT Next 3Y71.57%
EBIT Next 5YN/A
FCF growth 1Y355.58%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y157.31%
OCF growth 3Y3.76%
OCF growth 5Y8.08%

INFUSYSTEM HOLDINGS INC / INFU FAQ

Can you provide the ChartMill fundamental rating for INFUSYSTEM HOLDINGS INC?

ChartMill assigns a fundamental rating of 6 / 10 to INFU.


What is the valuation status for INFU stock?

ChartMill assigns a valuation rating of 6 / 10 to INFUSYSTEM HOLDINGS INC (INFU). This can be considered as Fairly Valued.


What is the profitability of INFU stock?

INFUSYSTEM HOLDINGS INC (INFU) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for INFU stock?

The Price/Earnings (PE) ratio for INFUSYSTEM HOLDINGS INC (INFU) is 29.12 and the Price/Book (PB) ratio is 2.82.